SCHEMBL4392247

SCHEMBL4392247

O=Cc1c(OCO)ccc2ccccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.68
NPC1 O15118 4/20 0.68
RAB9A P51151 4/20 0.68
L3MBTL1 Q9Y468 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
TDP1 Q9NUW8 2/20 0.66
GAA P10253 1/20 0.66
ADRB2 P07550 1/20 0.62
ADRB1 P08588 1/20 0.62
CYP1A2 P05177 2/20 0.58
CYP2C9 P11712 2/20 0.58
CYP2C19 P33261 2/20 0.58
ERN1 O75460 1/20 0.54
HPGD P15428 5/20 0.48
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 3/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NPSR1 Q6W5P4 3/20 0.44
LMNA P02545 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28765646 0.87 L3MBTL1 (0.71) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL12290142 0.86 MAPT (0.71) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL29844427 0.83 L3MBTL1 (0.75) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL10783231 0.83 MAPT (0.68) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL1253291 0.83 L3MBTL1 (0.75) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL24682276 0.83 L3MBTL1 (0.70) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL31573999 0.83 MAPT (0.68) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL2560912 0.83 L3MBTL1 (0.67) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL2560084 0.81 MAPT (0.61) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL2998966 0.81 L3MBTL1 (0.86) MAPTNPC1RAB9AL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090304620-A1 HAIR TREATMENT PRODUCTS COMPRISING POLYMERS HENKEL AG & CO. KGAA (DE) 2009-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090304620-A1 HAIR TREATMENT PRODUCTS COMPRISING POLYMERS ASS1, SRM, COL1A1 MAPT 1499/4885NPC1 4811/4885RAB9A 4866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.